Redox Limited (ASX:RDX)

Australia · Delayed Price · Currency is AUD

3.160

+0.040 (1.28%)

Feb 26, 2026, 3:59 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Wholesale - Drugs	1.24B	1.14B	1.26B	1.08B	796.34M
Wholesale - Drugs Growth	9.36%	-9.56%	16.24%	35.85%	10.84%
Total	1.24B	1.14B	1.26B	1.08B	796.34M
Total Growth	9.36%	-9.56%	16.24%	35.85%	10.84%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Australia	1.06B	965.15M	1.06B	925.93M	-
Australia Growth	9.33%	-9.23%	14.84%	-	-
New Zealand	103.86M	86.56M	107.12M	89.43M	-
New Zealand Growth	19.99%	-19.20%	19.78%	-	-
Others	9.63M	7.71M	11.05M	12.92M	-
Others Growth	24.87%	-30.24%	-14.49%	-	-
USA	75.08M	77.91M	76.01M	53.53M	-
USA Growth	-3.64%	2.49%	41.99%	-	-
Malaysia	-	-	-	-	12.92M
Malaysia Growth	-	-	-	-	117.62%
USA and Mexico	-	-	-	-	53.53M
Australia and New Zealand	-	-	-	-	1.02B
Total	1.24B	1.14B	1.26B	1.08B	1.08B
Total Growth	9.36%	-9.56%	16.24%	0%	50.57%

Source: S&P Global Market Intelligence.